Next Generation
Cell Therapy
About Us
TrophiCell is founded on a proprietary cell technology platform that will enable us to harness the full clinical potential of Mesenchymal Stromal Cells (MSCs).
TrophiCell therapies will exploit the responsive trophic repair and immunomodulatory properties of MSCs at an unprecedented scale that can deliver standardised advanced medicinal products that are optimised for a range of clinical indications.
We will work in partnership with the global best in class manufacturers of cell therapeutic products and clinical centres to deliver life enhancing and life saving treatments for patients to address areas of currently unmet clinical needs.
“TrophiCells – innovating excellence in cell therapeutics”
Our Technology
The MSC therapeutic landscape is currently divided between companies favouring the safety of natural MSCs (as demonstrated by almost 30 years of clinical trials)
Our Vision
The TrophiCell Vision is to develop and deliver the safest and most clinically effective cell therapeutics to patients.
Our Team
Members of our Senior Executive Team have working relationships spanning over 20 years and a shared ambition to make TrophiCells the leading clinical choice in cell therapeutics.